Theravance (THRX) in Focus: Stock Adds 5.0%

Zacks

Theravance Inc. (THRX) was a big mover last session, as the company saw its shares rise by a little over 5% on the day. The move came on solid volume too with far more shares changing hands than in a normal session. This stock, trading at a volatile range of $34.40–$37.86 in the past one-month time frame, showed a pick-up on Friday at $37.34.

None of the estimates for this biopharmaceutical company moved up or down over the past one month. Also, the Zacks Consensus Estimate remained unchanged. The recent price action is encouraging though, so make sure to keep a close watch on this firm in the near future.

Theravance currently has a Zacks Rank #3 (Hold) while its Earnings ESP is 0.00%.

Investors interested in the med-biomed/gene industry may also consider stocks such as Actelion Ltd. (ALIOF), AMAG Pharmaceuticals, Inc. (AMAG) and Discovery Laboratories Inc. (DSCO). While Actelion holds a Zacks Rank #1 (Strong Buy), AMAG Pharmaceuticals and Discovery Laboratories carry a Zacks Rank #2 (Buy).

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report >>


THERAVANCE INC (THRX): Free Stock Analysis Report

ACTELION LTD (ALIOF): Free Stock Analysis Report

AMAG PHARMACEUTICALS INC (AMAG): Free Stock Analysis Report

DISCOVERY LABORATORIES NEW (DSCO): Free Stock Analysis Report


Zacks Investment Research

Rates

View Comments (0)